nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—semen—acquired immunodeficiency syndrome	0.0311	0.4	CbGeAlD
Carbimazole—TPO—lymphoid tissue—acquired immunodeficiency syndrome	0.0155	0.199	CbGeAlD
Carbimazole—TPO—digestive system—acquired immunodeficiency syndrome	0.0153	0.197	CbGeAlD
Carbimazole—CYP19A1—blood—acquired immunodeficiency syndrome	0.00415	0.0534	CbGeAlD
Carbimazole—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.00337	0.0434	CbGeAlD
Carbimazole—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.00324	0.0418	CbGeAlD
Carbimazole—CYP19A1—brain—acquired immunodeficiency syndrome	0.00257	0.0332	CbGeAlD
Carbimazole—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.00249	0.032	CbGeAlD
Carbimazole—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00234	0.00253	CcSEcCtD
Carbimazole—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.00234	0.00253	CcSEcCtD
Carbimazole—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.00234	0.00253	CcSEcCtD
Carbimazole—Hepatitis—Efavirenz—acquired immunodeficiency syndrome	0.00232	0.00252	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00232	0.00251	CcSEcCtD
Carbimazole—Neutropenia—Saquinavir—acquired immunodeficiency syndrome	0.00231	0.00251	CcSEcCtD
Carbimazole—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00231	0.0025	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.00227	0.00246	CcSEcCtD
Carbimazole—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.00226	0.00245	CcSEcCtD
Carbimazole—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.00226	0.00245	CcSEcCtD
Carbimazole—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.00226	0.00244	CcSEcCtD
Carbimazole—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.00226	0.00244	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00225	0.00244	CcSEcCtD
Carbimazole—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00224	0.00243	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00224	0.00243	CcSEcCtD
Carbimazole—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00242	CcSEcCtD
Carbimazole—Stomatitis—Ritonavir—acquired immunodeficiency syndrome	0.00223	0.00242	CcSEcCtD
Carbimazole—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.00223	0.00242	CcSEcCtD
Carbimazole—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.00222	0.00241	CcSEcCtD
Carbimazole—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.00222	0.00241	CcSEcCtD
Carbimazole—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.00222	0.00241	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00221	0.00239	CcSEcCtD
Carbimazole—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.00221	0.00239	CcSEcCtD
Carbimazole—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.0022	0.00238	CcSEcCtD
Carbimazole—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00238	CcSEcCtD
Carbimazole—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00219	0.00238	CcSEcCtD
Carbimazole—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00217	0.00236	CcSEcCtD
Carbimazole—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.00217	0.00236	CcSEcCtD
Carbimazole—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00233	CcSEcCtD
Carbimazole—Stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00233	CcSEcCtD
Carbimazole—Ill-defined disorder—Zidovudine—acquired immunodeficiency syndrome	0.00214	0.00232	CcSEcCtD
Carbimazole—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00212	0.0023	CcSEcCtD
Carbimazole—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00212	0.0023	CcSEcCtD
Carbimazole—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00212	0.00229	CcSEcCtD
Carbimazole—Infection—Abacavir—acquired immunodeficiency syndrome	0.00212	0.00229	CcSEcCtD
Carbimazole—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00211	0.00229	CcSEcCtD
Carbimazole—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00211	0.00228	CcSEcCtD
Carbimazole—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.0021	0.00228	CcSEcCtD
Carbimazole—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.0021	0.00228	CcSEcCtD
Carbimazole—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00209	0.00226	CcSEcCtD
Carbimazole—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00209	0.00226	CcSEcCtD
Carbimazole—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.00208	0.00225	CcSEcCtD
Carbimazole—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00207	0.00224	CcSEcCtD
Carbimazole—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00207	0.00224	CcSEcCtD
Carbimazole—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00206	0.00223	CcSEcCtD
Carbimazole—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00206	0.00223	CcSEcCtD
Carbimazole—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.00206	0.00223	CcSEcCtD
Carbimazole—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.00205	0.00223	CcSEcCtD
Carbimazole—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00222	CcSEcCtD
Carbimazole—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00222	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00204	0.00221	CcSEcCtD
Carbimazole—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00199	0.00216	CcSEcCtD
Carbimazole—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.00199	0.00215	CcSEcCtD
Carbimazole—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.00215	CcSEcCtD
Carbimazole—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.00215	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00198	0.00214	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00197	0.00214	CcSEcCtD
Carbimazole—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00197	0.00213	CcSEcCtD
Carbimazole—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.00196	0.00213	CcSEcCtD
Carbimazole—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.00213	CcSEcCtD
Carbimazole—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.00212	CcSEcCtD
Carbimazole—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.00212	CcSEcCtD
Carbimazole—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.00196	0.00212	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00195	0.00211	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00194	0.0021	CcSEcCtD
Carbimazole—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00194	0.0021	CcSEcCtD
Carbimazole—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00193	0.0021	CcSEcCtD
Carbimazole—Malaise—Indinavir—acquired immunodeficiency syndrome	0.00193	0.00209	CcSEcCtD
Carbimazole—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00189	0.00205	CcSEcCtD
Carbimazole—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00188	0.00203	CcSEcCtD
Carbimazole—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00202	CcSEcCtD
Carbimazole—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00185	0.002	CcSEcCtD
Carbimazole—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00185	0.002	CcSEcCtD
Carbimazole—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00184	0.002	CcSEcCtD
Carbimazole—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00184	0.00199	CcSEcCtD
Carbimazole—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00183	0.00199	CcSEcCtD
Carbimazole—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00183	0.00198	CcSEcCtD
Carbimazole—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.00182	0.00198	CcSEcCtD
Carbimazole—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00182	0.00198	CcSEcCtD
Carbimazole—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00182	0.00198	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00181	0.00196	CcSEcCtD
Carbimazole—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00195	CcSEcCtD
Carbimazole—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.0018	0.00195	CcSEcCtD
Carbimazole—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00195	CcSEcCtD
Carbimazole—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00179	0.00194	CcSEcCtD
Carbimazole—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00178	0.00193	CcSEcCtD
Carbimazole—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00177	0.00192	CcSEcCtD
Carbimazole—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00177	0.00192	CcSEcCtD
Carbimazole—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00176	0.00191	CcSEcCtD
Carbimazole—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00175	0.0019	CcSEcCtD
Carbimazole—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.00175	0.0019	CcSEcCtD
Carbimazole—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.00189	CcSEcCtD
Carbimazole—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00173	0.00188	CcSEcCtD
Carbimazole—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00172	0.00187	CcSEcCtD
Carbimazole—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00172	0.00187	CcSEcCtD
Carbimazole—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00172	0.00187	CcSEcCtD
Carbimazole—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00172	0.00187	CcSEcCtD
Carbimazole—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00172	0.00187	CcSEcCtD
Carbimazole—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00172	0.00186	CcSEcCtD
Carbimazole—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00171	0.00186	CcSEcCtD
Carbimazole—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00186	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00171	0.00186	CcSEcCtD
Carbimazole—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00171	0.00186	CcSEcCtD
Carbimazole—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00185	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00171	0.00185	CcSEcCtD
Carbimazole—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00171	0.00185	CcSEcCtD
Carbimazole—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00184	CcSEcCtD
Carbimazole—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.0017	0.00184	CcSEcCtD
Carbimazole—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00169	0.00183	CcSEcCtD
Carbimazole—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00168	0.00183	CcSEcCtD
Carbimazole—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00167	0.00181	CcSEcCtD
Carbimazole—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.0018	CcSEcCtD
Carbimazole—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00165	0.00179	CcSEcCtD
Carbimazole—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00179	CcSEcCtD
Carbimazole—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00179	CcSEcCtD
Carbimazole—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00163	0.00177	CcSEcCtD
Carbimazole—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00162	0.00176	CcSEcCtD
Carbimazole—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00176	CcSEcCtD
Carbimazole—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00175	CcSEcCtD
Carbimazole—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00161	0.00175	CcSEcCtD
Carbimazole—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.0016	0.00174	CcSEcCtD
Carbimazole—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.00174	CcSEcCtD
Carbimazole—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.0016	0.00173	CcSEcCtD
Carbimazole—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.0016	0.00173	CcSEcCtD
Carbimazole—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00159	0.00173	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00159	0.00173	CcSEcCtD
Carbimazole—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00158	0.00172	CcSEcCtD
Carbimazole—Rash—Didanosine—acquired immunodeficiency syndrome	0.00157	0.0017	CcSEcCtD
Carbimazole—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00157	0.0017	CcSEcCtD
Carbimazole—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00157	0.0017	CcSEcCtD
Carbimazole—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00157	0.0017	CcSEcCtD
Carbimazole—Headache—Didanosine—acquired immunodeficiency syndrome	0.00156	0.00169	CcSEcCtD
Carbimazole—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00168	CcSEcCtD
Carbimazole—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00155	0.00168	CcSEcCtD
Carbimazole—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00155	0.00168	CcSEcCtD
Carbimazole—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00154	0.00167	CcSEcCtD
Carbimazole—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00153	0.00166	CcSEcCtD
Carbimazole—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00153	0.00166	CcSEcCtD
Carbimazole—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00153	0.00166	CcSEcCtD
Carbimazole—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00165	CcSEcCtD
Carbimazole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.00165	CcSEcCtD
Carbimazole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.00165	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00151	0.00164	CcSEcCtD
Carbimazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00151	0.00163	CcSEcCtD
Carbimazole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00151	0.00163	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0015	0.00163	CcSEcCtD
Carbimazole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.0015	0.00163	CcSEcCtD
Carbimazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00149	0.00162	CcSEcCtD
Carbimazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00149	0.00161	CcSEcCtD
Carbimazole—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00161	CcSEcCtD
Carbimazole—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00148	0.0016	CcSEcCtD
Carbimazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00147	0.00159	CcSEcCtD
Carbimazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00147	0.00159	CcSEcCtD
Carbimazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00147	0.00159	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00146	0.00158	CcSEcCtD
Carbimazole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00157	CcSEcCtD
Carbimazole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00144	0.00156	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00156	CcSEcCtD
Carbimazole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00155	CcSEcCtD
Carbimazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00155	CcSEcCtD
Carbimazole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00154	CcSEcCtD
Carbimazole—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00141	0.00153	CcSEcCtD
Carbimazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00141	0.00153	CcSEcCtD
Carbimazole—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0014	0.00152	CcSEcCtD
Carbimazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00152	CcSEcCtD
Carbimazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00152	CcSEcCtD
Carbimazole—Infection—Saquinavir—acquired immunodeficiency syndrome	0.0014	0.00151	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.00151	CcSEcCtD
Carbimazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00139	0.0015	CcSEcCtD
Carbimazole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.0015	CcSEcCtD
Carbimazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00138	0.0015	CcSEcCtD
Carbimazole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00149	CcSEcCtD
Carbimazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00149	CcSEcCtD
Carbimazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00137	0.00148	CcSEcCtD
Carbimazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00137	0.00148	CcSEcCtD
Carbimazole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00148	CcSEcCtD
Carbimazole—Rash—Stavudine—acquired immunodeficiency syndrome	0.00136	0.00148	CcSEcCtD
Carbimazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00136	0.00148	CcSEcCtD
Carbimazole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00147	CcSEcCtD
Carbimazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00136	0.00147	CcSEcCtD
Carbimazole—Headache—Stavudine—acquired immunodeficiency syndrome	0.00135	0.00147	CcSEcCtD
Carbimazole—Rash—Abacavir—acquired immunodeficiency syndrome	0.00134	0.00146	CcSEcCtD
Carbimazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00134	0.00145	CcSEcCtD
Carbimazole—Headache—Abacavir—acquired immunodeficiency syndrome	0.00133	0.00145	CcSEcCtD
Carbimazole—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00144	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00144	CcSEcCtD
Carbimazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00133	0.00144	CcSEcCtD
Carbimazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00144	CcSEcCtD
Carbimazole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.00143	CcSEcCtD
Carbimazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00142	CcSEcCtD
Carbimazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00131	0.00142	CcSEcCtD
Carbimazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00131	0.00141	CcSEcCtD
Carbimazole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00141	CcSEcCtD
Carbimazole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00141	CcSEcCtD
Carbimazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00129	0.0014	CcSEcCtD
Carbimazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00129	0.0014	CcSEcCtD
Carbimazole—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00128	0.00139	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00139	CcSEcCtD
Carbimazole—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00126	0.00137	CcSEcCtD
Carbimazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00125	0.00136	CcSEcCtD
Carbimazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00125	0.00135	CcSEcCtD
Carbimazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00134	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00132	CcSEcCtD
Carbimazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.00132	CcSEcCtD
Carbimazole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00131	CcSEcCtD
Carbimazole—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Carbimazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Carbimazole—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Carbimazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00127	CcSEcCtD
Carbimazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00126	CcSEcCtD
Carbimazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00126	CcSEcCtD
Carbimazole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00126	CcSEcCtD
Carbimazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00125	CcSEcCtD
Carbimazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00121	CcSEcCtD
Carbimazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00121	CcSEcCtD
Carbimazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00112	0.00121	CcSEcCtD
Carbimazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.0012	CcSEcCtD
Carbimazole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.0012	CcSEcCtD
Carbimazole—Rash—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00119	CcSEcCtD
Carbimazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00119	CcSEcCtD
Carbimazole—Headache—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00119	CcSEcCtD
Carbimazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00117	CcSEcCtD
Carbimazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00116	CcSEcCtD
Carbimazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00115	CcSEcCtD
Carbimazole—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Carbimazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Carbimazole—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Carbimazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00112	CcSEcCtD
Carbimazole—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00112	CcSEcCtD
Carbimazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00112	CcSEcCtD
Carbimazole—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000996	0.00108	CcSEcCtD
Carbimazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000995	0.00108	CcSEcCtD
Carbimazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000995	0.00108	CcSEcCtD
Carbimazole—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00099	0.00107	CcSEcCtD
Carbimazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000988	0.00107	CcSEcCtD
Carbimazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000981	0.00106	CcSEcCtD
Carbimazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000949	0.00103	CcSEcCtD
Carbimazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000938	0.00102	CcSEcCtD
Carbimazole—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000921	0.000999	CcSEcCtD
Carbimazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00092	0.000998	CcSEcCtD
Carbimazole—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000915	0.000992	CcSEcCtD
Carbimazole—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000887	0.000961	CcSEcCtD
Carbimazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000886	0.00096	CcSEcCtD
Carbimazole—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000881	0.000955	CcSEcCtD
Carbimazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000868	0.000941	CcSEcCtD
Carbimazole—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000846	0.000917	CcSEcCtD
Carbimazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000845	0.000916	CcSEcCtD
Carbimazole—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00084	0.000911	CcSEcCtD
Carbimazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000835	0.000905	CcSEcCtD
Carbimazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000797	0.000864	CcSEcCtD
